Drug Profile
Tacedinaline
Alternative Names: Ac-Din; Acetyldinaline; CI 994; GOE 5549; PD 123654; PD 130636Latest Information Update: 06 Mar 2008
Price :
$50
*
At a glance
- Originator Goedecke; Pfizer
- Developer Pfizer
- Class Aniline compounds; Antineoplastics
- Mechanism of Action Angiogenesis inhibitors; Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Lung cancer; Pancreatic cancer
Most Recent Events
- 06 Mar 2008 Discontinued - Phase-I for Colorectal cancer in USA (PO)
- 06 Mar 2008 Discontinued - Phase-II for Breast cancer in USA (PO)
- 06 Mar 2008 Discontinued - Phase-II for Lung cancer in USA (PO)